Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Migraine

  Free Subscription


Articles published in Neurology

Retrieve available abstracts of 98 articles:
HTML format



Single Articles


    March 2025
  1. KELLIER D, Anto MM, Hall M, Marin J, et al
    Association of Race and Ethnicity With Emergency Room Rate of Migraine Diagnosis, Testing, and Management in Children With Headache.
    Neurology. 2025;104:e213351.
    PubMed     Abstract available


  2. SCHRAMM S, Borner-Schroder C, Reichert M, Ramschutz C, et al
    Consensus Recommendations to Establish Reporting Standards in fMRI of Migraine: A Delphi Study.
    Neurology. 2025;104:e210235.
    PubMed     Abstract available


    February 2025
  3. HOFFMANN J, Kaube H, Rimmele F, Jurgens TP, et al
    Kinetic Oscillation Stimulation for the Preventive Treatment of Chronic Migraine: A Randomized, Double-Blind, Sham-Controlled Trial.
    Neurology. 2025;104:e210220.
    PubMed     Abstract available


    January 2025
  4. LIPTON RB, Gandhi P, Tassorelli C, Reuter U, et al
    Early Improvements With Atogepant for the Preventive Treatment of Migraine: Results From 3 Randomized Phase 3 Trials.
    Neurology. 2025;104:e210212.
    PubMed     Abstract available


  5. LUBOTZKY A, Pai V, Branson HM, Chowdhury SS, et al
    Teaching NeuroImage: Stroke-Like Migraine Attacks After Radiation Therapy Syndrome.
    Neurology. 2025;104:e210203.
    PubMed    


    December 2024
  6. BONNESEN K, Fuglsang CH, Schmidt M
    Impact of Nonsteroidal Anti-Inflammatory Drug Use on the Migraine-Associated Risk of Myocardial Infarction and Ischemic Stroke: A Population-Based Cohort Study.
    Neurology. 2024;103:e210034.
    PubMed     Abstract available


  7. WANG K, Sico JJ
    Treating Migraine Patients With Cardiovascular Risks: Are NSAIDs the Safer Choice?
    Neurology. 2024;103:e210196.
    PubMed    


    November 2024

  8. Efficacy of Atogepant in Chronic Migraine With and Without Acute Medication Overuse in the Randomized, Double-Blind, Phase 3 PROGRESS Trial.
    Neurology. 2024;103:e209868.
    PubMed    


  9. ALLEN C, Rastall DP
    Teaching NeuroImage: Alice in Wonderland Syndrome: Anatomic Correlation.
    Neurology. 2024;103:e209957.
    PubMed    



  10. Sex-Specific Association of Cardiovascular Risk Factors With Migraine: The Population-Based Rotterdam Study.
    Neurology. 2024;103:e210022.
    PubMed    


    September 2024
  11. KUMAR A, Joshi D, Singh VK
    Harlequin Syndrome: A Rare Association With Migraine.
    Neurology. 2024;103:e209792.
    PubMed    


  12. SCHULZ RS, Glatz T, Buring JE, Rist PM, et al
    Migraine and Risk of Parkinson Disease in Women: A Cohort Study.
    Neurology. 2024;103:e209747.
    PubMed     Abstract available


  13. LIPTON RB, Harriott AM, Ma JY, Smith JH, et al
    Effect of Ubrogepant on Patient-Reported Outcomes When Administered During the Migraine Prodrome: Results From the Randomized PRODROME Trial.
    Neurology. 2024;103:e209745.
    PubMed     Abstract available


    August 2024
  14. AL-HASSANY L, Acarsoy C, Ikram MK, Bos D, et al
    Sex-Specific Association of Cardiovascular Risk Factors With Migraine: The Population-Based Rotterdam Study.
    Neurology. 2024;103:e209700.
    PubMed     Abstract available


    July 2024
  15. GOADSBY PJ, Friedman DI, Holle-Lee D, Demarquay G, et al
    Efficacy of Atogepant in Chronic Migraine With and Without Acute Medication Overuse in the Randomized, Double-Blind, Phase 3 PROGRESS Trial.
    Neurology. 2024;103:e209584.
    PubMed     Abstract available


    May 2024
  16. CHRISTENSEN RH, Ashina H, Al-Khazali HM, Zhang Y, et al
    Differences in Cortical Morphology in People With and Without Migraine: A Registry for Migraine (REFORM) MRI Study.
    Neurology. 2024;102:e209305.
    PubMed     Abstract available


  17. REUTER U, Goadsby PJ, Ferrari MD, Da Silva Lima GP, et al
    Efficacy and Safety of Erenumab in Participants With Episodic Migraine in Whom 2-4 Prior Preventive Treatments Had Failed: LIBERTY 3-Year Study.
    Neurology. 2024;102:e209349.
    PubMed     Abstract available


    April 2024
  18. DE HAVENON A, Callaghan BC, Xu Y, Connor M, et al
    Burden of Neurologic Health Care and Incident Neurologic Diagnoses in the Year After COVID-19 or Influenza Hospitalization.
    Neurology. 2024;102:e209248.
    PubMed     Abstract available


  19. VAN OOSTERHOUT WPJ, Perenboom MJL, Terwindt GM, Ferrari MD, et al
    Frequency and Clinical Features of Space Headache Experienced by Astronauts During Long-Haul Space Flights.
    Neurology. 2024;102:e209224.
    PubMed     Abstract available


    February 2024
  20. LATEEF TM, Dey D, Leroux A, Cui L, et al
    Association Between Electronic Diary-Rated Sleep, Mood, Energy, and Stress With Incident Headache in a Community-Based Sample.
    Neurology. 2024;102:e208102.
    PubMed     Abstract available


  21. PIZER JH, Aita SL, Myers MA, Hawley NA, et al
    Neuropsychological Function in Migraine Headaches: An Expanded Comprehensive Multidomain Meta-Analysis.
    Neurology. 2024;102:e208109.
    PubMed     Abstract available


  22. SHAPIRO RE, Nicholson RA, Seng EK, Buse DC, et al
    Migraine-Related Stigma and Its Relationship to Disability, Interictal Burden, and Quality of Life.
    Neurology. 2024;102:e208074.
    PubMed     Abstract available


  23. KEMPNER J
    Brains Under Siege: Assessing the Harmful Effects of Migraine-Related Stigma.
    Neurology. 2024;102:e209192.
    PubMed    


    January 2024
  24. HVITFELDT FUGLSANG C, Pedersen L, Schmidt M, Vandenbroucke JP, et al
    Combined Impact of Migraine and Pregnancy-Induced Hypertension on Long-term Risk of Premature Myocardial Infarction and Stroke.
    Neurology. 2024;102:e207813.
    PubMed     Abstract available


    November 2023
  25. CHIANG CC, Fang X, Horvath Z, Cadiou F, et al
    Simultaneous Comparisons of 25 Acute Migraine Medications Based on 10 Million Users' Self-Reported Records From a Smartphone Application.
    Neurology. 2023 Nov 29:10.1212/WNL.0000000000207964.
    PubMed     Abstract available


  26. FRIEDMAN SA, Robbins MS
    Millions of Migraine Attacks, Many Answers, More Questions.
    Neurology. 2023 Nov 29:10.1212/WNL.0000000000208084.
    PubMed    


    August 2023
  27. FRIEDMAN BW, Solorzano C, Kessler BD, Martorello K, et al
    Randomized Trial Comparing Low- vs High-Dose IV Dexamethasone for Patients With Moderate to Severe Migraine.
    Neurology. 2023 Aug 21:10.1212/WNL.0000000000207648.
    PubMed     Abstract available


  28. VANDERPLUYM JH, Victorio MCC, Oakley CB, Rastogi RG, et al
    Beyond the Guidelines: A Narrative Review of Treatments on the Horizon for Migraine in Children and Adolescents.
    Neurology. 2023 Aug 21:10.1212/WNL.0000000000207677.
    PubMed     Abstract available


    July 2023
  29. VANDERPLUYM JH
    Variation in Endpoints in FDA Approvals for Acute and Preventive Migraine Medications: Striving to Compare Apples to Apples.
    Neurology. 2023 Jul 12:10.1212/WNL.0000000000207672.
    PubMed    


  30. SHARPLESS LK, Kesselheim A, Orr SL, Darrow J, et al
    Variation in Endpoints in FDA Medication Approvals: A Review of Acute and Preventive Migraine Medications.
    Neurology. 2023 Jul 12:10.1212/WNL.0000000000207544.
    PubMed     Abstract available


  31. PONDER M, Wood ME
    Periconceptional Use of OnabotulinumtoxinA: Need for Comparative Safety Studies.
    Neurology. 2023;101:53-54.
    PubMed    


    June 2023
  32. LIU J, Quan S, Zhao L, Yuan K, et al
    Evaluation of a Clustering Approach to Define Distinct Subgroups of Patients With Migraine to Select Electroacupuncture Treatments.
    Neurology. 2023 Jun 22:10.1212/WNL.0000000000207484.
    PubMed     Abstract available


    May 2023
  33. ORNELLO R, Sposato LA, Sacco S
    Author Response: Microembolism and Other Links Between Migraine and Stroke: Clinical and Pathophysiologic Update.
    Neurology. 2023;100:1033.
    PubMed    


  34. LEWIS A, Galetta S
    Editors' Note: Microembolism and Other Links Between Migraine and Stroke: Clinical and Pathophysiologic Update.
    Neurology. 2023;100:1032.
    PubMed    


  35. SCUTELNIC A, Jung S, Schankin CJ
    Reader Response: Microembolism and Other Links Between Migraine and Stroke: Clinical and Pathophysiologic Update.
    Neurology. 2023;100:1032-1033.
    PubMed    


    April 2023
  36. KARCESKI S
    Migraine and Hormones: A Complex Interaction.
    Neurology. 2023;100:e1849-e1851.
    PubMed    


  37. BARBANTI P, Aurilia C, Egeo G, Torelli P, et al
    Late Response to Anti-CGRP Monoclonal Antibodies in Migraine: A Multicenter, Prospective, Observational Study.
    Neurology. 2023 Apr 18:10.1212/WNL.0000000000207292.
    PubMed     Abstract available



  38. Efficacy and Safety of Eptinezumab in Patients With Chronic Migraine: PROMISE-2.
    Neurology. 2023 Apr 4:10.1212/WNL.0000000000207168.
    PubMed    


    March 2023
  39. BENKLI B, Kim SY, Koike N, Han C, et al
    Circadian Features of Cluster Headache and Migraine: A Systematic Review, Meta-analysis, and Genetic Analysis.
    Neurology. 2023 Mar 29:10.1212/WNL.0000000000207240.
    PubMed     Abstract available


  40. SUTHERLAND H, Griffiths L
    It's All About the Timing: Circadian Factors in Cluster Headache and Migraine.
    Neurology. 2023 Mar 29:10.1212/WNL.0000000000207329.
    PubMed    


    February 2023
  41. RAFFAELLI B, Storch E, Overeem LH, Terhart M, et al
    Sex Hormones and Calcitonin Gene-Related Peptide in Women With Migraine: A Cross-sectional, Matched Cohort Study.
    Neurology. 2023 Feb 22:10.1212/WNL.0000000000207114.
    PubMed     Abstract available


    January 2023
  42. VANDERPLUYM JH
    Adverse Pregnancy Outcomes and Migraine: What We Know and What We Can Do.
    Neurology. 2023 Jan 25:10.1212/WNL.0000000000207089.
    PubMed    


  43. PURDUE-SMITHE AC, Stuart JJ, Farland LV, Kang JH, et al
    Prepregnancy Migraine, Migraine Phenotype, and Risk of Adverse Pregnancy Outcomes.
    Neurology. 2023 Jan 19:10.1212/WNL.0000000000206831.
    PubMed     Abstract available


  44. LAX DN, Kabbouche M, Kacperski J, Hershey AD, et al
    Clinical Reasoning: A Teenager With Right-Sided Headache and Periorbital Changes.
    Neurology. 2023;100:144-150.
    PubMed     Abstract available


  45. HORTON MK, Robinson SC, Shao X, Quach H, et al
    A Cross-Trait, Mendelian Randomization Study to Investigate Whether Migraine Is a Risk Factor for Multiple Sclerosis.
    Neurology. 2023 Jan 11:10.1212/WNL.0000000000206791.
    PubMed     Abstract available


    December 2022
  46. UNDERWOOD M, Achana F, Carnes D, Eldridge S, et al
    A Supportive Self-Management Program for People With Chronic Headaches and Migraine: A Randomized Controlled Trial and Economic Evaluation.
    Neurology. 2022 Dec 16:10.1212/WNL.0000000000201518.
    PubMed     Abstract available


  47. SACCO S, Harriott AM, Ayata C, Ornello R, et al
    Microembolism and Other Links Between Migraine and Stroke: Clinical and Pathophysiologic Update.
    Neurology. 2022 Dec 15:10.1212/WNL.0000000000201699.
    PubMed     Abstract available


    November 2022
  48. LIPTON RB, Pozo-Rosich P, Blumenfeld A, Li Y, et al
    Effect of Atogepant for Preventive Migraine Treatment on Patient-Reported Outcomes in the Randomized, Double-blind, Phase 3 ADVANCE Trial.
    Neurology. 2022 Nov 17. pii: WNL.0000000000201568.
    PubMed     Abstract available


  49. KOPEL D, Gottschalk CH
    Migraine--Not Just a Numbers Game: Aim to Improve Quality of Life.
    Neurology. 2022 Nov 17. pii: WNL.0000000000201566.
    PubMed    


    October 2022
  50. DE VRIES LENTSCH S, Heleen van der Arend BW, Maassen van den Brink A, Terwindt GM, et al
    Blood Pressure in Migraine Patients Treated With Monoclonal Anti-CGRP (receptor) Antibodies: A Prospective Follow-up Study.
    Neurology. 2022 Oct 4. pii: WNL.0000000000201008.
    PubMed     Abstract available


    September 2022
  51. ORR SL
    Status Migrainosus: One of the Most Poorly Understood but Important Complications of Migraine.
    Neurology. 2022 Sep 29. pii: WNL.0000000000201477.
    PubMed    


  52. VANDERPLUYM JH, Mangipudi K, Mbonde AA, Gritsch D, et al
    Incidence of Status Migrainosus in Olmsted County, Minnesota, United States: Characterization and Predictors of Recurrence.
    Neurology. 2022 Sep 29. pii: WNL.0000000000201382.
    PubMed     Abstract available


  53. AILANI J, Kaiser EA, Mathew PG, McAllister P, et al
    Role of Calcitonin Gene-Related Peptide on the Gastrointestinal Symptoms of Migraine-Clinical Considerations: A Narrative Review.
    Neurology. 2022 Sep 20. pii: WNL.0000000000201332.
    PubMed     Abstract available


  54. SENG EK, Fenton BT, Wang K, Lipton RB, et al
    Frequency, Demographics, Comorbidities, and Health Care Utilization by Veterans With Migraine: A VA Nationwide Cohort Study.
    Neurology. 2022 Sep 13. pii: WNL.0000000000200888.
    PubMed     Abstract available


    August 2022
  55. IGHODARO E, Ghislain B, Scharf E, Robertson CE, et al
    Pearls & Oysters: Post Pipeline Headache Phenomenon: Nummular Headache Presenting After Intracranial Aneurysm Stenting.
    Neurology. 2022 Aug 26. pii: WNL.0000000000201157.
    PubMed     Abstract available


  56. IBRAHIMI K, Rist PM, Carpenet C, Lee Rohmann J, et al
    Vascular Risk Score and Associations With Past, Current, or Future Migraine in Women: Cohort Study.
    Neurology. 2022 Aug 19. pii: WNL.0000000000201009.
    PubMed     Abstract available


  57. SACCO S, Sposato LA
    The Challenging Puzzle of Migraine, Age, and Vascular Health.
    Neurology. 2022 Aug 19. pii: WNL.0000000000201071.
    PubMed    


  58. ADDERLEY NJ, Subramanian A, Perrins M, Nirantharakumar K, et al
    Headache, Opiate Use, and Prescribing Trends in Women With Idiopathic Intracranial Hypertension: A Population-Based Matched Cohort Study.
    Neurology. 2022 Aug 19. pii: WNL.0000000000201064.
    PubMed     Abstract available


  59. LIPTON RB, Dodick D, Goadsby PJ, Burstein R, et al
    Efficacy of Ubrogepant in the Acute Treatment of Migraine With Mild Pain Versus Moderate or Severe Pain.
    Neurology. 2022 Aug 17. pii: WNL.0000000000201031.
    PubMed     Abstract available


  60. GALLARDO VJ, Alpuente A, Pozo-Rosich P
    Association of a Cyclical Migraine Phenotype With Disease Progression: A One-Year Time Series Analysis.
    Neurology. 2022 Aug 11. pii: WNL.0000000000200887.
    PubMed     Abstract available


    July 2022
  61. COFFMAN C, Reyes D, Hess MC, Giakas AM, et al
    Relationship Between Headache Characteristics and a Remote History of TBI in Veterans: A 10-Year Retrospective Chart Review.
    Neurology. 2022;99:e187-e198.
    PubMed     Abstract available


  62. ROSENDALE N, Guterman EL, Obedin-Maliver J, Flentje A, et al
    Migraine, Migraine Disability, Trauma, and Discrimination in Sexual and Gender Minority Individuals.
    Neurology. 2022 Jul 11. pii: WNL.0000000000200941.
    PubMed     Abstract available


    April 2022
  63. MORRIS C, Ross A, Greene K, Irwin S, et al
    Outcomes That Matter to Adolescents With Continuous Headache Due to Chronic Migraine and Their Parents: A Pilot Survey Study.
    Neurology. 2022 Apr 13. pii: WNL.0000000000200292.
    PubMed     Abstract available


    March 2022
  64. DOHRN MF, Rebelo AP, Srivastava S, Cappuccio G, et al
    De Novo ATP1A1 Variants in an Early-Onset Complex Neurodevelopmental Syndrome.
    Neurology. 2022;98:440-445.
    PubMed     Abstract available


    February 2022
  65. SCHER AI, Bendtsen L
    Patient-Centered Treatment of Chronic Migraine With Medication Overuse: More Is Not Always Better.
    Neurology. 2022 Feb 15. pii: WNL.0000000000200252.
    PubMed    


  66. MCELWEE DECKER B, Thibault D, Davis KA, Willis AW, et al
    Population-Based Study of Nonelective Postpartum Readmissions in Women With Stroke, Migraine, Multiple Sclerosis, and Myasthenia Gravis.
    Neurology. 2022 Feb 15. pii: WNL.0000000000200007.
    PubMed     Abstract available


  67. SCHWEDT T, Hentz J, Sahai-Srivastava S, Murinova N, et al
    Patient-Centered Treatment of Chronic Migraine With Medication Overuse: A Prospective, Randomized, Pragmatic Clinical Trial.
    Neurology. 2022 Feb 15. pii: WNL.0000000000200117.
    PubMed     Abstract available


    January 2022
  68. DUMKRIEGER G, Chong CD, Ross K, Berisha V, et al
    Differentiating Between Migraine and Post-traumatic Headache Using a Machine Learning Classifier.
    Neurology. 2022;98.
    PubMed     Abstract available


  69. ISHII R, Dodick DW, Trivedi M, Dumkrieger G, et al
    A History of Mild Traumatic Brain Injury Is Associated With a a More Severe Long-term Migraine Phenotype.
    Neurology. 2022;98.
    PubMed     Abstract available


    October 2021
  70. MACGREGOR EA
    Differences Between Perimenstrual Migraine Attacks and Migraine Attacks at Other Times of the Cycle.
    Neurology. 2021;97:e1753-e1756.
    PubMed    


  71. RIANT F, Roos C, Roubertie A, Barbance C, et al
    Hemiplegic Migraine Associated With PRRT2 Mutations: A Clinical and Genetic Study.
    Neurology. 2021 Oct 14. pii: WNL.0000000000012947.
    PubMed     Abstract available


  72. GUO Y, Daghlas I, Gormley P, Giulianini F, et al
    Phenotypic and Genotypic Associations Between Migraine and Lipoprotein Subtractions.
    Neurology. 2021 Oct 11. pii: WNL.0000000000012919.
    PubMed     Abstract available


    September 2021
  73. STANYER EC, Creeney H, Nesbitt AD, Robert Holland PR, et al
    Subjective Sleep Quality and Sleep Architecture in Patients With Migraine: A Meta-analysis.
    Neurology. 2021 Sep 22. pii: WNL.0000000000012701.
    PubMed     Abstract available


  74. KAISER EA, McAdams H, Igdalova A, Haggerty EB, et al
    Reflexive Eye Closure in Response to Cone and Melanopsin Stimulation: A Study of Implicit Measures of Light Sensitivity in Migraine.
    Neurology. 2021 Sep 7. pii: WNL.0000000000012734.
    PubMed     Abstract available


  75. VAN CASTEREN DS, Verhagen IE, van der Arend BWH, van Zwet EW, et al
    Comparing Perimenstrual and Nonperimenstrual Migraine Attacks Using an e-Diary.
    Neurology. 2021 Sep 7. pii: WNL.0000000000012723.
    PubMed     Abstract available


    August 2021
  76. SCHANKIN CJ, Denier N, El-Koussy M, Wiest R, et al
    Author Response: The Index Vein Pointing to the Origin of the Migraine Aura Symptom: A Case Series.
    Neurology. 2021;97:402.
    PubMed    


  77. BUGNICOURT JM, Godefroy O
    Reader Response: The Index Vein Pointing to the Origin of the Migraine Aura Symptom: A Case Series.
    Neurology. 2021;97:401-402.
    PubMed    


    July 2021
  78. CARVALHO G, Mehnert J, Basedau H, Luedtke K, et al
    Brain Processing of a Visual Self-Motion Study in Patients With Migraine: An fMRI Study.
    Neurology. 2021 Jul 21. pii: WNL.0000000000012443.
    PubMed     Abstract available


    April 2021
  79. MACDONALD CJ, El Fatouhi D, Madika AL, Fagherazzi G, et al
    Association of Migraine With Incident Hypertension After Menopause: A Longitudinal Cohort Study.
    Neurology. 2021 Apr 21. pii: WNL.0000000000011986.
    PubMed     Abstract available


  80. GHANIZADA H, Al-Mahdi Al-Karagholi M, Arngrim N, Morch-Rasmussen M, et al
    Effect of Adrenomedullin on Migraine-like Attacks in Patients With Migraine: A Randomized Crossover Study.
    Neurology. 2021 Apr 7. pii: WNL.0000000000011930.
    PubMed     Abstract available


  81. LIPTON RB, Buse DC, Friedman BW
    Author Response: Characterizing Opioid Use in a US Population With Migraine: Results From the CaMEO Study.
    Neurology. 2021;96:686.
    PubMed    


  82. MINEN MT
    Reader Response: Characterizing Opioid Use in a US Population With Migraine: Results From the CaMEO Study.
    Neurology. 2021;96:685.
    PubMed    


  83. LIPTON RB, Buse DC, Friedman BW
    Author Response: Characterizing Opioid Use in a US Population With Migraine: Results From the CaMEO Study.
    Neurology. 2021;96:684-685.
    PubMed    


  84. BLUMENFELD A
    Reader Response: Characterizing Opioid Use in a US Population With Migraine: Results From the CaMEO Study.
    Neurology. 2021;96:684.
    PubMed    


  85. LIPTON RB, Buse DC, Friedman BW
    Author Response: Characterizing Opioid Use in a US Population With Migraine: Results From the CaMEO Study.
    Neurology. 2021;96:683-684.
    PubMed    


  86. GUPTA VK
    Reader Response: Characterizing Opioid Use in a US Population With Migraine: Results From the CaMEO Study.
    Neurology. 2021;96:683.
    PubMed    


  87. GANESH A, Galetta S
    Editors' Note: Characterizing Opioid Use in a US Population With Migraine: Results From the CaMEO Study.
    Neurology. 2021;96:682.
    PubMed    


  88. GUO Y, Rist PM, Sabater Lleal M, de Vries P, et al
    Association Between Hemostatic Profile and Migraine: A Mendelian Randomization Analysis.
    Neurology. 2021 Apr 1. pii: WNL.0000000000011931.
    PubMed     Abstract available


    February 2021
  89. YU AYX, Hill MD, Asdaghi N, Boulanger JM, et al
    Sex Differences in Diagnosis and Diagnostic Revision of Suspected Minor Cerebral Ischemic Events.
    Neurology. 2021;96:e732-e739.
    PubMed     Abstract available


    January 2021
  90. VAN CASTEREN DS, Kurth T, Danser AHJ, Terwindt GM, et al
    Sex Differences in Response to Triptans: A Systematic Review and Meta-analysis.
    Neurology. 2021;96:162-170.
    PubMed     Abstract available


    November 2020
  91. RIGGINS NY, Sawhney H, Ehrlich A, Parekh M, et al
    Inpatient infusion treatments of headache in patients with chronic migraine and a reported history of head trauma and endocrine co-morbidities.
    Neurology. 2020;95.
    PubMed     Abstract available


  92. ROBBINS MS, Victorio MC, Bailey M, Cook C, et al
    Quality improvement in neurology: Headache Quality Measurement Set.
    Neurology. 2020;95:866-873.
    PubMed    


    October 2020
  93. LIPTON RB, Fanning KM, Buse DC, Martin VT, et al
    Author response: Migraine progression in subgroups of migraine based on comorbidities: Results of the CaMEO Study.
    Neurology. 2020;95:707-708.
    PubMed    


  94. GUPTA VK
    Reader response: Migraine progression in subgroups of migraine based on comorbidities: Results of the CaMEO Study.
    Neurology. 2020;95:707.
    PubMed    


  95. SIEGLER JE 3RD, Galetta S
    Editors' note: Migraine progression in subgroups of migraine based on comorbidities: Results of the CaMEO Study.
    Neurology. 2020;95:706.
    PubMed    


  96. SASIKUMAR S, Micieli JA, Oh J
    Mystery Case: Migraine, hearing loss, and blurred vision in a young woman.
    Neurology. 2020 Oct 12. pii: WNL.0000000000011034.
    PubMed    


    September 2020
  97. KORNBLUH AB, Chung MG
    Teaching NeuroImages: Transient cytotoxic edema in a child with a novel ATP1A2 mutation.
    Neurology. 2020;95:e1441-e1442.
    PubMed    


    August 2020
  98. SALTER A, Kowalec K, Fitzgerald KC, Cutter G, et al
    Comorbidity is associated with disease activity in MS: Findings from the CombiRx trial.
    Neurology. 2020;95:e446-e456.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Migraine is free of charge.